Live Agbiotech updates | Page 12

Live Agbiotech news coverage of developments with the latest updates. Stay on top of latest Agbiotech news stories and find out what just happened, what is going on with Agbiotech. The latest real-time news updates and headlines on Agbiotech
Mission to BioKorea to strengthen ties
EpiAxis Therapeutics appoints new chief science officer
Zelria Therapeutics executes acquisition of Health House
Botanix confirms presentation of data at upcoming congress
Imugene says first cohort two patient dose in phase 1 clinical trial
Microbio is step closer to launching its InfectID-BSI tests in Europe
Rhonomed completes institutional component of capital raise
Australian Pavilion returns in-person to BIO 2022
MTPConnect announces support for major new resilience projects
Race receives human ethics approval for new trial
Microba announces new research partnership and senior appointment
Australian healthcare investor urges greater support from peers
Avecho reports positive results for Phase 2 topical CBD osteoarthritis study
NTCELL to be produced in Australia under UTS research agreement
Government launches biotechnology - strategic plan for health and medicine
Dimerix receives R&D tax rebate for last financial year
Neuren receives FDA approval for Pitt Hopkins IND and Phase 2 trial
BioScience Managers welcomes FDA approval of Saluda technology
Large molecule facility doubles size of leading bioanalytical laboratory
Industry concerned by leaked Covid vaccine IP waiver text
Biotron updates on pre-clinical study of BIT225 in Covid
US FDA grants new orphan designation to Noxopharm's Veyonda
Access savings by registering early for AusMedtech 2022
Paradigm secures UK approvals for PARA_OA_002 clinical trial
First Participants dosed in ENA Respiratory's phase 2a study
WA funding programmes open
Neuren receives ethics approval for Angelman Phase 2 trial
'Gold standard' commercialisation for biotech
Partnership encourages innovation in how Australian universities and industry collaborate
Telix's ZIRCON late-stage kidney cancer imaging study completes enrolment
Rebrand for Australia's largest life sciences venture fund
Victoria's Medtech Manufacturing Capability Programme opens
Recognition for Vetter in CMO Leadership Awards
Chimeric Therapeutics announces final results from Phase 1 trial of CORE NK Platform
International Women's Day: AusBiotech 'moving dial' on gender equity
Antisense Therapeutics confirms ATL1102 poster presentation
New expedited regulatory pathway proposed for novel biologicals
Approval for Neuren Pharmaceuticals' Phase 2 trial in Angelman syndrome
Patrys selects stable cell line for production of PAT-DX3
Lucy Turnbull AO rejoins board of Immutep
AusBiotech highlights clarity and transparency is key in recent submissions
Kazia Therapeutics to be 'transformed' by pipeline progress
New award recognises industry's role in clinical trials
Arovella Therapeutics closes over-subscribed share purchase plan
Important support programme oversubscribed
Amplia says new report 'paves way' for its phase 2 trial
Engage early on reimbursement and regulation strategies
Vaccine developer Sementis appoints chief operating officer